Sevoflurane's Effect on Neurocognition Study (NCT06044740) | Clinical Trial Compass
CompletedEarly Phase 1
Sevoflurane's Effect on Neurocognition Study
United States42 participantsStarted 2024-01-17
Plain-language summary
The purpose of this study is to determine the effects of acute pain on long-term memory and conditioned physiologic responses in the presence and absence of low dose sevoflurane. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will occur over 2 visits and involves no long-term follow up.
Who can participate
Age range18 Years – 59 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults, age 18-59, who are native English speakers with at least a high school education
* have normal hearing and memory
* be of normal body-weight
* be generally healthy (free from significant chronic disease)
* have none of the specific exclusion criteria
* have a valid email address and valid phone number throughout the study
* anticipate ability to participate in all visits required for the phase of the study in which they are enrolled
Exclusion Criteria:
* being pregnant or attempting to conceive
* having a body mass index (BMI) \> 35
* having significant memory impairment or hearing loss
* having sleep apnea
* having chronic pain or frequently taking pain medication (including tramadol)
* having any severe or poorly-controlled medical problem (hypertension, diabetes)
* having neurologic or psychiatric disease, including anxiety, and depression
* having significant cardiac valvular disease or cardiomyopathy
* having a history of abnormal heartbeats (cardiac conduction abnormality or arrhythmia)
* having a history of seizures or convulsions
* having a history of liver disease
* having a history of asthma or other significant pulmonary disease
* having a history of malignant hyperthermia, muscular dystrophy, central core disease, or hyperkalemia
* being claustrophobic
* have metal implants or non-removable metal piercings
* having a history of adverse reaction to anesthetics
* daily alcohol or heavy alcohol use; history of alcohol abuse
* current …
What they're measuring
1
functional magnetic resonance imaging activation in response to experimental tasks
Timeframe: Visit 1: Immediate; average activity, calculated from each task scan
2
Functional connectivity
Timeframe: Visit 1: Immediate; brain activity captured in data acquired across entire 6-8 minute scan.